ArticleScientific reports2025
Predictive analysis of solubility data with pressure and temperature in assessing nanomedicine preparation via supercritical carbon dioxide.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Automated machine-learning framework for predicting drug solubility in supercritical COScientific reports · 2026Article
- Accelerating supercritical pharmaceutical formulation via interpretable data-driven prediction of drug solubility.Scientific reports · 2026Article
- Application of machine learning models in pharmaceutical engineering for prediction of pharmaceuticals solubility in supercritical solvent: study on phenytoin solubility.Frontiers in chemistry · 2026Article
- Data-driven prediction of lipophilic drug solubility in supercritical COFrontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This work presents a comprehensive study on the prediction of phenytoin solubility at supercritical state using advanced techniques including machine learning analysis. The solubility of small-molecule pharmaceutical was analyzed and calculated to enhance its solubility and bioavailability as well. The models were employed to approximate the solubility at various pressures and temperatures. The dataset comprises temperature (T), pressure (P), and solubility (y) values, along with the corresponding solvent density measurements that were used in the models. Three models, namely Automatic Relevance Determination Regression (ARD), Gaussian process regression (GPR), and Linear Regression (LR) were designed and tuned to build predictive models. The ADABOOST ensemble technique was applied to strengthen the predictive capabilities of the models, while hyperparameter tuning was conducted using the Jellyfish Optimization (JO) algorithm. For phenytoin solubility prediction, the ADA-GPR model demonstrated outstanding accuracy, obtaining an R² of 0.99644. The ADA-LR model also produced competitive results, attaining an R² value of 0.93381, whereas the ADA-ARD model showed robust performance, yielding an R² of 0.95249. In terms of solvent density prediction, the ADA-GPR model once again outperformed the others, with an R² value of 0.9933.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.